Profile data is unavailable for this security.
About the company
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members (Members). Its products include meal replacements, protein shakes, teas, aloes, high-protein snacks, vitamins and supplements, sports nutrition and outer nutrition products. The Company offers a range of meal replacement products, such as protein shakes, bars and soups. Its snack portfolio includes a variety of sweet, savory and creamy options, such as high protein iced coffee, protein bars, snack shakes, soups, baking mixes and others. Its Herbal Aloe Concentrate is a beverage formulated with aloe vera, which can be mixed with water, tea or protein shake. It has also developed a portfolio of dietary supplements, encompassing solutions for heart health, digestive health, immunity and others. It sells products in 95 markets across the world.
- Revenue in USD (TTM)5.07bn
- Net income in USD137.20m
- Incorporated2002
- Employees9.20k
- LocationHerbalife LtdUgland House, South Church StreetP.O. Box 309GtGRAND CAYMAN 00000Cayman IslandsCYM
- Phone+1 3453 104109600
- Fax+1 3 102587019
- Websitehttps://www.herbalife.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YSB Inc | 2.35bn | -441.78m | 677.68m | 6.31k | -- | 2.55 | -- | 0.2883 | -25.64 | -25.64 | 47.51 | 3.24 | -- | -- | -- | 2,908,872.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Nu Skin Enterprises, Inc. | 1.90bn | -3.31m | 677.96m | 3.70k | -- | 0.8373 | 9.82 | 0.3559 | -0.0758 | -0.0758 | 37.80 | 16.30 | 1.07 | 1.90 | 29.99 | 514,858.10 | -0.1858 | 6.80 | -0.2298 | 8.90 | 68.42 | 73.45 | -0.174 | 5.26 | 1.24 | 7.94 | 0.3736 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| Uniphar PLC | 2.78bn | 48.72m | 791.03m | 3.26k | 16.24 | 2.19 | 9.03 | 0.285 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| NanJing Pharmaceutical Co Ltd | 7.40bn | 81.36m | 888.69m | 4.90k | 10.86 | 0.9634 | -- | 0.1201 | 0.4513 | 0.4513 | 41.07 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Selcuk Ecza Deposu Ticaret ve Sanayi AS | 3.03bn | 6.93m | 974.87m | 6.03k | 140.64 | 2.08 | 49.00 | 0.3212 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
| Neuca SA | 3.01bn | 37.31m | 1.06bn | 5.19k | 29.03 | 4.19 | 15.18 | 0.3521 | 32.42 | 32.42 | 2,617.05 | 224.63 | 2.38 | 7.47 | 7.13 | 2,276,477.00 | 3.21 | 3.58 | 12.45 | 13.31 | 11.07 | 10.33 | 1.35 | 1.43 | 0.4725 | 4.33 | 0.3336 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | -- |
| Herbalife Ltd | 5.07bn | 137.20m | 1.09bn | 9.20k | 7.94 | -- | 4.32 | 0.2145 | 1.37 | 1.37 | 50.57 | -10.39 | 1.90 | 2.25 | 58.67 | 551,586.90 | 5.14 | 11.30 | 8.68 | 18.70 | 76.80 | 78.43 | 2.70 | 6.02 | 0.7667 | 2.98 | 1.76 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
| DocMorris AG | 1.07bn | -129.32m | 1.11bn | 1.45k | -- | 1.91 | -- | 1.04 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
| Guangxi LiuYao Group Co Ltd | 2.94bn | 123.04m | 1.27bn | 5.58k | 9.36 | 1.20 | -- | 0.432 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
| Sigma Healthcare Ltd | 2.29bn | 3.02m | 1.35bn | 156.00 | 312.66 | 2.23 | 59.92 | 0.5898 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 9.95m | 9.97% |
| The WindAcre Partnership LLCas of 31 Mar 2024 | 9.20m | 9.22% |
| Route One Investment Co. LPas of 31 Mar 2024 | 8.63m | 8.65% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 6.98m | 7.00% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 6.48m | 6.49% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 5.96m | 5.97% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 5.94m | 5.95% |
| UBS Securities LLCas of 31 Mar 2024 | 5.28m | 5.29% |
| BMO Asset Management Corp.as of 31 Mar 2024 | 3.27m | 3.28% |
| Camber Capital Management LPas of 31 Mar 2024 | 3.00m | 3.01% |
